Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Total cholesterol/HDL ratio
Clinical narrative: COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067H21A, 001C21A and 020B21A) for COVID-19 prophylaxis.     The patient's past medical history included Anxiety in 2001, Depression in 2001, Hyperlipidemia, Dyslipidemia on 31-Mar-2021, BP raised (Has had occasional episodes of BP in 140s), Impaired fasting glucose on 31-Mar-2021, Laryngopharyngeal reflux on 31-Mar-2021, Renal artery thrombosis on 16-Nov-2023, Extraction of impacted wisdom teeth in 1998 and Tonsillectomy in 1997. Family history included Depression (Mother), Diabetes (Father), Coronary artery disease (Father (57 age), Maternal Grandmother (65 age), Maternal Grandfather (65 age)), ADHD (Brother), Immunodeficiency (Brother, genetic, unsure type) and Cancer (Maternal Grandfather). Concurrent medical conditions included Dust allergy, Ragweed allergy, ADD since 2000, Right lower quadrant pain (with subsequent workup revealing rt renal infarct with acute thrombus.) since 16-Nov-2023, Non-smoker, Non-tobacco user, Alcohol use (3.0 standard drinks of alcohol), Hyponatremia, Raynaud's disease (He has been noticing raynaud's phenomenon in his fingers and toes with temperature changes), Right inguinal hernia (small fat containing right inguinal hernia without inflammatio), Ileus and Ileus. Concomitant products included AMPHETAMINE for ADD, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) from 01-Jan-2009 to an unknown date, MULTIVITAMIN [VITAMINS NOS] from 01-Jan-2000 to an unknown date, COLECALCIFEROL, DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID, RETINOL (OMEGA 3 [COLECALCIFEROL;DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;RETINOL]) from 01-Jan-2013 to an unknown date, OMEGA-3 FATTY ACIDS, MAGNESIUM and VITAMIN D3 for an unknown indication.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 18-Sep-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Blood cholesterol: 168. On 31-Mar-2021, Glycosylated haemoglobin: 5.5. On 31-Mar-2021, High density lipoprotein: 35. On 31-Mar-2021, Total cholesterol/HDL ratio: 4.8. On 18-Sep-2022, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 18-Sep-2022, the patient took rapid test at home which showed positive covid-19.  Treatment medication information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-750831 (Patient Link).